SE304513B - - Google Patents

Info

Publication number
SE304513B
SE304513B SE27767A SE27767A SE304513B SE 304513 B SE304513 B SE 304513B SE 27767 A SE27767 A SE 27767A SE 27767 A SE27767 A SE 27767A SE 304513 B SE304513 B SE 304513B
Authority
SE
Sweden
Application number
SE27767A
Inventor
A Gagneux
F Haefliger
C Eugster
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of SE304513B publication Critical patent/SE304513B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE27767A 1963-12-06 1967-01-09 SE304513B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
SE304513B true SE304513B (fr) 1968-09-30

Family

ID=4405150

Family Applications (3)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (fr) 1963-12-06 1964-12-04
SE27767A SE304513B (fr) 1963-12-06 1967-01-09
SE27667A SE303507B (fr) 1963-12-06 1967-01-09

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (fr) 1963-12-06 1964-12-04

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE27667A SE303507B (fr) 1963-12-06 1967-01-09

Country Status (12)

Country Link
US (1) US3242190A (fr)
AT (2) AT249054B (fr)
BE (1) BE656759A (fr)
CH (1) CH427803A (fr)
DE (1) DE1445848A1 (fr)
DK (4) DK106796C (fr)
ES (5) ES306818A1 (fr)
FR (2) FR1427775A (fr)
GB (1) GB1034939A (fr)
IL (1) IL22568A (fr)
NL (1) NL6414138A (fr)
SE (3) SE301652B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130992C (fr) * 1964-09-14
DK150615C (da) * 1982-10-26 1987-11-09 Cheminova As Fremgangsmaade til fremstilling af substituerede 3-isoxazololer
CA2430298A1 (fr) 2000-11-30 2002-06-06 Banavara Lakshman Mylari Combinaison d'agonistes gaba et d'inhibiteurs de la sorbitol-deshydrogenase (sdi)
WO2002043763A2 (fr) 2000-11-30 2002-06-06 Pfizer Products Inc. Combinaison de gaba-agonistes et d'inhibiteurs d'aldose-réductase
CA2525366A1 (fr) * 2003-05-16 2004-11-25 Pfizer Products Inc. Combinaisons therapeutiques d'antipsychotiques atypiques avec des modulateurs de l'acide 4-aminobutanoique et/ou des medicaments anticonvulsivants
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
WO2005082372A1 (fr) * 2004-01-29 2005-09-09 Pfizer Products Inc. COMBINAISON DE MODULATEURS D'ACIDE γ-AMINOBUTYRIQUE ET D'ANTAGONISTES DU RECEPTEUR 5-HT1B
EP2258358A3 (fr) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenèse avec un inhibiteur de l'acetylcholinestérase
EP2275095A3 (fr) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese par modulation des recepteurs muscariniques
EP1940389A2 (fr) 2005-10-21 2008-07-09 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2382975A3 (fr) 2006-05-09 2012-02-29 Braincells, Inc. Neurogénèse par modulation d'angiotensine
JP2009536667A (ja) * 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド 5ht受容体介在性の神経新生
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine

Also Published As

Publication number Publication date
ES306817A1 (es) 1965-05-16
ES306818A1 (es) 1965-05-16
AT250348B (de) 1966-11-10
FR4139M (fr) 1966-05-02
BE656759A (fr) 1965-06-08
CH427803A (de) 1967-01-15
DK106796C (da) 1967-03-20
SE303507B (fr) 1968-09-02
AT249054B (de) 1966-09-26
GB1034939A (en) 1966-07-06
US3242190A (en) 1966-03-22
ES306816A1 (es) 1965-05-16
DK106797C (da) 1967-03-20
DE1445848A1 (de) 1968-11-21
ES306820A1 (es) 1965-05-16
IL22568A (en) 1968-04-25
SE301652B (fr) 1968-06-17
ES306819A1 (es) 1965-05-16
DK106733C (da) 1967-03-13
FR1427775A (fr) 1966-02-11
DK108169C (da) 1967-10-02
NL6414138A (fr) 1965-06-07

Similar Documents

Publication Publication Date Title
AR142945A1 (fr)
BE641143A (fr)
FR4139M (fr)
AT260747B (fr)
BE627012A (fr)
BE644956A (fr)
BE507458A (fr)
BE465565A (fr)
BE462764A (fr)
BE31062A (fr)
BE547422A (fr)
BE645790A (fr)
BE603935A (fr)
BE608372A (fr)
BE571209A (fr)
BE612803A (fr)
BE645676A (fr)
BE642986A (fr)
BE643337A (fr)
BE645116A (fr)
BE645034A (fr)
BE626867A (fr)
BE644758A (fr)
BE644431A (fr)
BE533484A (fr)